Latest Evidence-based medicine Stories
DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/5x8d4c/molecular) has announced the addition of a new report "Molecular
EINDHOVEN and LEIDEN, The Netherlands, April 3, 2014 /PRNewswire/ -- The combined resources of two leading technology institutes are set to create a new wave of public-private
Using Evidence-Based Value Analysis to Drive Quality Improvement Will Be the Focus Lansdale, PA (PRWEB) April 02, 2014 Hayes, Inc., a leader in promoting
Doctor Evidence, a leading specialty software platform and services company serving the healthcare ecosystem appoints Jeff Frimpter, MPH as Vice President of Clients Solutions to lead the company’s
Panel Will Provide Expertise on Trial Selection, Design and Implementation WASHINGTON, March 25, 2014 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI)
GIA announces the release of a comprehensive global report on Personalized Medicines markets.
Partnership Seeks To Establish Clinical and Health Economic Benefits of Trovagene's Urine-Based Cell-Free Molecular Diagnostics for Potential Adoption in Cancer Management Strategies SAN
In what's thought to be the biggest review of academic literature into whether home care visits provide benefits for the elderly, researchers conclude there is 'no consistent evidence' to show they lead to the elderly living longer or having more independent lives than those without any visits.
LONDON, March 10, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.